INFI 100mg (Truseltiq 100 mg)
Generic Name: infigratinib
Pill with imprint INFI 100mg is Orange & White, Capsule-shape and has been identified as Truseltiq 100 mg. It is supplied by BridgeBio Pharma, Inc.
Truseltiq is used in the treatment of biliary tract tumor and belongs to the drug class multikinase inhibitors. Truseltiq 100 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for INFI 100mg
Truseltiq
- Generic Name
- infigratinib
- Imprint
- INFI 100mg
- Strength
- 100 mg
- Color
- Orange & White
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Multikinase inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- BridgeBio Pharma, Inc.
- National Drug Code (NDC)
- 72730-0111
More about Truseltiq (infigratinib)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy
- Imprints, shape & color data
- Pricing & coupons
- En español
- Drug class: multikinase inhibitors
- FDA approval history
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.